Non-invasive marker-independent high content analysis of a microphysiological human pancreas-on-a-chip model.


Journal

Matrix biology : journal of the International Society for Matrix Biology
ISSN: 1569-1802
Titre abrégé: Matrix Biol
Pays: Netherlands
ID NLM: 9432592

Informations de publication

Date de publication:
01 2020
Historique:
received: 30 03 2019
revised: 20 06 2019
accepted: 20 06 2019
pubmed: 27 6 2019
medline: 13 2 2021
entrez: 26 6 2019
Statut: ppublish

Résumé

The increasing prevalence of diabetes, its heterogeneity, and the limited number of treatment options drive the need for physiologically relevant assay platforms with human genetic background that have the potential to improve mechanistic understanding and e\xpedite diabetes-related research and treatment. In this study, we developed an endocrine pancreas-on-a-chip model based on a tailored microfluidic platform, which enables self-guided trapping of single human pseudo-islets. Continuous, low-shear perfusion provides a physiologically relevant microenvironment especially important for modeling and monitoring of the endocrine function as well as sufficient supply with nutrients and oxygen. Human pseudo-islets, generated from the conditionally immortalized EndoC-βH3 cell line, were successfully injected by hydrostatic pressure-driven flow without altered viability. To track insulin secretion kinetics in response to glucose stimulation in a time-resolved manner, dynamic sampling of the supernatant as well as non-invasive real-time monitoring using Raman microspectroscopy was established on-chip. Dynamic sampling indicated a biphasic glucose-stimulated insulin response. Raman microspectroscopy allowed to trace glucose responsiveness in situ and to visualize different molecular structures such as lipids, mitochondria and nuclei. In-depth spectral analyses demonstrated a glucose stimulation-dependent, increased mitochondrial activity, and a switch in lipid composition of insulin secreting vesicles, supporting the high performance of our pancreas-on-a-chip model.

Identifiants

pubmed: 31238092
pii: S0945-053X(19)30149-0
doi: 10.1016/j.matbio.2019.06.008
pii:
doi:

Substances chimiques

Insulin 0
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

205-220

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Aline Zbinden (A)

Dept. of Women's Health, Research Institute of Women's Health, Eberhard Karls University Tübingen, Germany.

Julia Marzi (J)

Dept. of Women's Health, Research Institute of Women's Health, Eberhard Karls University Tübingen, Germany; The Natural and Medical Sciences Institute (NMI) at the University of Tübingen, Reutlingen, Germany.

Katharina Schlünder (K)

Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB), Stuttgart, Germany.

Christopher Probst (C)

Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB), Stuttgart, Germany.

Max Urbanczyk (M)

Dept. of Women's Health, Research Institute of Women's Health, Eberhard Karls University Tübingen, Germany.

Scott Black (S)

The Natural and Medical Sciences Institute (NMI) at the University of Tübingen, Reutlingen, Germany.

Eva M Brauchle (EM)

Dept. of Women's Health, Research Institute of Women's Health, Eberhard Karls University Tübingen, Germany; The Natural and Medical Sciences Institute (NMI) at the University of Tübingen, Reutlingen, Germany.

Shannon L Layland (SL)

Dept. of Women's Health, Research Institute of Women's Health, Eberhard Karls University Tübingen, Germany.

Udo Kraushaar (U)

The Natural and Medical Sciences Institute (NMI) at the University of Tübingen, Reutlingen, Germany.

Garry Duffy (G)

Discipline of Anatomy and the Regenerative Medicine Institute, School of Medicine, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Ireland; Science Foundation Ireland (SFI), Centre for Research in Advanced Materials for Biomedical Engineering (AMBER), Trinity College Dublin, National University of Ireland Galway, Galway, Ireland.

Katja Schenke-Layland (K)

Dept. of Women's Health, Research Institute of Women's Health, Eberhard Karls University Tübingen, Germany; The Natural and Medical Sciences Institute (NMI) at the University of Tübingen, Reutlingen, Germany; Dept. of Medicine/Cardiology, University of California Los Angeles (UCLA), Los Angeles, CA, USA. Electronic address: katja.schenke-layland@med.uni-tuebingen.de.

Peter Loskill (P)

Dept. of Women's Health, Research Institute of Women's Health, Eberhard Karls University Tübingen, Germany; Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB), Stuttgart, Germany. Electronic address: peter.loskill@uni-tuebingen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH